Security record · archived quarter
FLGT
Fulgent Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
8Tracked holders
—Δ holders
1.93MShares held
$37.93MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | -6 | 10.73M | $220.18M | +4 | −10 |
| Q1 2026 | 69 | 0 | 11.71M | $186.24M | +4 | −4 |
| Q4 2025 | 69 | +1 | 14.16M | $372.03M | +1 | — |
| Q3 2025 | 14 | 0 | 9.19M | $207.61M | — | — |
| Q2 2025 | 11 | -2 | 7.55M | $150.07M | — | −2 |
| Q1 2025 | 10 | +1 | 3.99M | $67.47M | +1 | — |
| Q4 2024 | 9 | -1 | 3.49M | $64.46M | — | −1 |
| Q3 2024 | 9 | +1 | 2.57M | $55.79M | +2 | −1 |
| Q2 2024 | 8 | — | 1.93M | $37.93M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 958.85K | — | $18.81M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 489.55K | — | $9.61M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 489.55K | — | $9.61M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 186.24K | — | $3.65M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 186.24K | — | $3.65M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 132.34K | — | $2.60M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (passive) | 85.36K | — | $1.67M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 43.90K | — | $861,318 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 22.21K | — | $435,701 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 14.86K | — | $292,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 156 holders, 16.99M shares, $249.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API